Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial

BACKGROUND: The treatment of Leishmaniasis caused by Leishmania (Viannia) guyanensis is based on a weak strength of evidence from very few clinical trials and some case series reports. Current treatment guidelines recommend pentamidine isethionate or meglumine antimoniate (Glucantime) as the first-l...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS Negl Trop Dis
Autori principali: Francesconi, Valeska Albuquerque, Francesconi, Fabio, Ramasawmy, Rajendranath, Romero, Gustavo Adolfo Sierra, Alecrim, Maria das Graças Costa
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5854414/
https://ncbi.nlm.nih.gov/pubmed/29481560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0006225
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi